AbataCept for the Treatment of Immune-cHeckpoint Inhibitors Induced mYocarditiS
Clinical trial NCT05195645 · COMPLETED
Trial details
- NCT number
- NCT05195645
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-27
- Primary completion
- 2024-03-05
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.